Journal of Controlled Release

Article	Citations
A PBPK model recapitulates early kinetics of anti-PEG antibody-mediated clearance of PEG-liposomes	542
Prediction of drug capturing by lipid emulsions in vivo for the treatment of a drug overdose	390
Outside Back Cover	326
In vivo self-assembled small RNA targets H19 lncRNA for the treatment of colorectal cancer	284
Inside Back Cover	284
Full-cycle study on developing a novel structured micromixer and evaluating the nanoparticle products as mRNA delivery carriers	266
Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination	264
Inside Back Cover	251
Corrigendum to “Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch” [Journal of Controlled Release 372 (2024) 304–317]	250
Outside Back Cover	246
Macrophage-targeting nano-formulated bicalutamide alleviates colitis by inducing MAP3K1-mediated degradation of NLRP3	244
Outside Front Cover: Yisheng Peng et al	230
The osteogenic and angiogenic potential of microRNA-26a delivered via a non-viral delivery peptide for bone repair	224
Tumor permeable self-delivery nanodrug targeting mitochondria for enhanced chemotherapy	211
Enhanced browning of adipose tissue by mirabegron-microspheres	206
Functional nanoplatform for modulating cellular forces to enhance antitumor immunity via mechanotransduction	193
Surface-engineered mesenchymal stem cell for refractory asthma therapy: Reversing airway remodeling	186
Adaptable peptide-based therapeutics modulating tumor microenvironment for combinatorial radio-immunotherapy	182
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine	180
Oxygen-boosted fluorinated prodrug hybrid nanoassemblies for bidirectional amplification of breast cancer ferroptosis	173
In vivo delivery of antioxidant enzymes with multi-functionalized lipid nanoparticles for sepsis therapy	171
Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy	169
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment	166
The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules	165
Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice	162

Combinatorial physical methods for cellular therapy: Towards the future of cellular analysis?	161
Nanoghosts: Mesenchymal Stem cells derived nanoparticles as a unique approach for cartilage regeneration	156
Mechanisms of uptake and transport of particulate formulations in the small intestine	155
Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy	148
Hybrid prodrug nanoassembly for hypoxia-triggered immunogenic chemotherapy and immune modulation	147
Dynamic versus static testing and in vivo mechanical performance of poly(glycolide-trimethylene carbonate-ε-caprolactone) delayed release implants	147
Down-regulation of TNF-α via macrophage-targeted RNAi system for the treatment of acute inflammatory sepsis	144
An efficient (nano) silica - In glucan particles protein encapsulation approach for improved thermal stability	141
Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases	139
Alendronate-functionalized polymeric micelles target icaritin to bone for mitigating osteoporosis in a rat model	135
A next-generation STING agonist MSA-2: From mechanism to application	134
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?	133
Identification of functional biomarkers for personalized nanomedicine in advanced breast cancer in vitro models	131
Unleashing the potential of cell biomimetic nanoparticles: Strategies and challenges in their design and fabrication for therapeutic applications	127
Transdermal carbon monoxide delivery	125
Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation	125
Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer	124
Outside Back Cover	122
Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy	121
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation	120
Mechanism exploration of intestinal mucus penetration of nano-Se: regulated by polysaccharides with different functional groups and molecular weights	120
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer	119
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome	119
Single-cell RNA transcriptome landscape of murine liver following systemic administration of mesoporous silica nanoparticles	119
Healing with precision: A multi-functional hydrogel-bioactive glass dressing boosts infected wound recovery and enhances neurogenesis in the wound bed	118
Cavitation-assisted sonothrombolysis by asymmetrical nanostars for accelerated thrombolysis	117
Conditioned media-integrated microneedles for hair regeneration through perifollicular angiogenesis	116
Impact of interferon-γ on the target cell tropism of nanoparticles	116
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma	115
Self-assembly hydrogels of therapeutic agents for local drug delivery	114
Nanoparticle-mediated thermal Cancer therapies: Strategies to improve clinical translatability	112
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors	109
Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure	108
Nano-trapping CXCL13 reduces regulatory B cells in tumor microenvironment and inhibits tumor growth	107
Integrative approaches to enhance adeno-associated viral gene delivery	107
Thermoresponsive polymeric dexamethasone prodrug for arthritis pain	104
Enhancing gene transfection of poly(β-amino ester)s through modulation of amphiphilicity and chain sequence	102
Autophagy-activating aluminum hydroxide nanovaccine for enhanced antigen presentation and anti-tumor immunity	99
Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization	98
Dual-stimulus phototherapeutic nanogel for triggering pyroptosis to promote cancer immunotherapy	98
Multifunctional nanoparticles potentiate in-situ tumor vaccines via reversing insufficient Photothermal therapy by disrupting tumor vasculature	98
The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs	97
Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy	96
Injectable nanocomposite hydrogel with cascade drug release for treatment of uveal melanoma	96
Orthogonal upconversion nanocarriers for combined photodynamic therapy and precisely triggered gene silencing in combating keloids	95
ZIF-8-modified hydrogel sequentially delivers angiogenic and osteogenic growth factors to accelerate vascularized bone regeneration	95
Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy	94
Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection	93
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment	93
MSC-derived extracellular vesicles as nanotherapeutics for promoting aged liver regeneration	92

Oral mucosal vaccination using integrated fiber microneedles	92
Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis	90
Complement opsonization of nanoparticles: Differences between humans and preclinical species	89
Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis	88
Development of a thermostable oxytocin microneedle patch	88
Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease	88
Extracellular vesicles for renal therapeutics: State of the art and future perspective	87
A smart cauliflower-like carrier for astaxanthin delivery to relieve colon inflammation	87
White paper: Understanding, informing and defining the regulatory science of microneedle-based dosage forms that are applied to the skin	87
Hydrogel-forming microarray patches with solid dispersion reservoirs for transdermal long-acting microdepot delivery of a hydrophobic drug	87
Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients	86
Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies	86
Melittin-incorporated nanomedicines for enhanced cancer immunotherapy	86
Ferroptosis boosted oral cancer photodynamic therapy by carrier-free Sorafenib-Ce6 self-assembly nanoparticles	85
An engineered dual function peptide to repair fractured bones	85
Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy	85
Biomimetic reactive oxygen/nitrogen nanoscavengers inhibit “ferroptosis storm” and modulate immune targeting for acute kidney injury	84
Nanomaterials applied in wound healing: Mechanisms, limitations and perspectives	83
Inside Front Cover	82
Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment	82
Outside Front Cover	82
Inside Back Cover	81
Inside Back Cover	81
Outside Front Cover	80
Inside front cover: Yufan Qian et al	80
Size matters: Altering antigen specific immune tolerance by tuning size of particles	80
Thermal/ultrasound-triggered release of liposomes loaded with Ganoderma applanatum polysaccharide from microbubbles for enhanced tumour ablation	79
Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes	79
Editorial Board	79
Modulation of GABAergic neurons in acute epilepsy using sonogenetics	78
Tet1 peptide and zinc (II)-adenine multifunctional module functionalized polycations as efficient siRNA carriers for Parkinson's disease	78
Strengthening scientific credibility in the face of misinformation and disinformation: Viable solutions	78
A polymer‑calcium phosphate nanocapsule for RNAi-induced oxidative stress and cascaded chemotherapy	78
Exploration of M2 macrophage membrane as a biotherapeutic agent and strong synergistic therapeutic effects in ischemic stroke	78
Low-boiling-point perfluorocarbon nanodroplets for adaptable ultrasound-induced blood-brain barrier opening	77
Programmed T cells infiltration into lung metastases with harnessing dendritic cells in cancer immunotherapies by catalytic antigen-capture sponges	76
Restoring tumor antigenicity activates the “bystander” T cell immune cycle	76
Outside Back Cover: Yujie Wang et al	75
Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential	74
Corrigendum to “Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision” [Journal of Controlled Release, Volume 379, 10 March 2025, Pages 12	74
Nanoparticle-mediated synergistic disruption of tumor innervation and redox homeostasis for potent antineoplastic therapy	73
Photothermal-controlled NO-releasing Nanogels reverse epithelial-mesenchymal transition and restore immune surveillance against cancer metastasis	73
Design of lipid-based formulations for oral delivery of a BASP1 peptide targeting MYC-dependent gastrointestinal cancer cells	73
Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules	73
Corrigendum to “Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy” [Journal of Controlled Release 353 (2023) 447–461]	72
Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes	72
In situ formed reactive oxygen species-responsive dipyridamole prodrug hydrogel: Spatiotemporal drug delivery for chemoimmunotherapy	71
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine	71
Nano-engineered immune cells as “guided missiles” for cancer therapy	71
Nano-chemical priming strategy to enhance TGF-β resistance and anti-tumor activity of natural killer cells	71
Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing	70
Microneedle patch-involved local therapy synergized with immune checkpoint inhibitor for pre- and post-operative cancer treatment	70
An “IgG-hitchhiking” approach for rapid tumor accumulation and clearance of photosensitizers	70
Orthogonal and complementary measurements of properties of drug products containing nanomaterials	69
Protein-based delivery systems for RNA delivery	69
Controlled release of manganese and magnesium ions by microsphere-encapsulated hydrogel enhances cancer immunotherapy	69
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity	69
A preparation method for mRNA-LNPs with improved properties	68
Substrate-free dissolving microneedles with barbed shape to increase adhesion and drug-delivery efficiency to skin	67
Engineered bacterial extracellular vesicles for central nervous system diseases	67
Nanoadjuvants Actively targeting lymph node conduits and blocking tumor invasion in lymphatic vessels	67
Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging	67
Chemo-photothermal nanoplatform with diselenide as the key for ferroptosis in colorectal cancer	67
Colonic drug delivery: Formulating the next generation of colon-targeted therapeutics	67
A trinity STING-activating nanoparticle harnesses cancer cell STING machinery for enhanced immunotherapy	67
Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins	67
An engineered α1β1 integrin-mediated FcγRI signaling component to control enhanced CAR macrophage activation and phagocytosis	67
Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis	66
Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy	66
Nebulized inhalation of LPAE-HDAC10 inhibits acetylation-mediated ROS/NF-κB pathway for silicosis treatment	66
Electrospun fibers for vaginal administration of tenofovir disoproxil fumarate and emtricitabine in the context of topical pre-exposure prophylaxis	66
COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice	66
Dual-corn-derived nanofiber membrane for subconjunctival injury: Sequential release of dual-natural products for programmed anti-inflammation and anti-fibrosis	66
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges	66
Acetyl-lysine human serum albumin nanoparticles activate CD44 receptors, with preferential uptake by cancer stem cells, leading to tumor eradication	66
Perspectives on complement and phagocytic cell responses to nanoparticles: From fundamentals to adverse reactions	66
Zeolite imidazolate framework-8 in bone regeneration: A systematic review	65
Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer	65
Advocation and advancements of EPR effect theory in drug delivery science: A commentary	65
Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections	65

Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine	65
Ion-paired moxifloxacin nanocrystal formulation improves treatment and prevention of ocular infection	65
Promotion or inhibition of extracellular vesicle release: Emerging therapeutic opportunities	64
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy	64
Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension	64
Yam-derived exosome-like nanovesicles stimulate osteoblast formation and prevent osteoporosis in mice	64
Hyperglycemia-responsive nitric oxide-releasing biohybrid cryogels with cascade enzyme catalysis for enhanced healing of infected diabetic wounds	64
A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy	64
Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route	63
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity	63
Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor	63
Nanodrugs based on co-delivery strategies to combat cisplatin resistance	63
Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer	63
Editorial Board	62
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment	62
Strategic aspects for the commercialization of nanomedicines	62
Macrophage membrane-encapsulated miRNA nanodelivery system for the treatment of hemophilic arthritis	62
Potent inhibition of MMP-9 by a novel sustained-release platform attenuates left ventricular remodeling following myocardial infarction	62
Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems	60
In situ vaccine “seeds” for enhancing cancer immunotherapy by exploiting apoptosis-associated morphological changes	60
Engineered macrophages acting as a trigger to induce inflammation only in tumor tissues	60
Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats	60
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product	60
Biomimetic-gasdermin-protein-expressing nanoplatform mediates tumor-specific pyroptosis for cancer immunotherapy	59
DNA nanotechnology-facilitated ligand manipulation for targeted therapeutics and diagnostics	59
Prospects for hypoxia-based drug delivery platforms for the elimination of advanced metastatic tumors: From 3D modeling to clinical concepts	58
Manganese-induced Photothermal-Ferroptosis for Synergistic Tumor Therapy	58
GOx-encapsulated iron-phenolic networks power catalytic cascade to eradicate bacterial biofilms	58
cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer	58
Next generation therapeutics for retinal neurodegenerative diseases	57
Outside Front Cover	57
Editorial Board	57
Inside Back Cover	57
LncRNA-edited biomimetic nanovaccines combined with anti-TIM-3 for augmented immune checkpoint blockade immunotherapy	57
Outside Back Cover	57
Inside Front Cover	57
Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy	56
Corrigendum to “Ultrasound-responsive polymersomes capable of endosomal escape for efficient cancer therapy” [Journal of Controlled Release 322 (2020) 81–94]	56
Engineering stable and non-immunogenic immunoenzymes for cancer therapy via in situ generated prodrugs	56
All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes	56
Nanoscale coordination polymers enabling antioxidants inhibition for enhanced chemodynamic therapy	56
Overcoming the blood-brain barrier? - prediction of blood-brain permeability of hydrophobically modified polyethylenimine polyplexes for siRNA delivery into the brain with in vitro and in vivo models	56
Corrigendum to “Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery” [Journal of Controlled Release	55
Tiny tots for a big-league in wound repair: Tools for tissue regeneration by nanotechniques of today	55
Modulating albumin-mediated transport of peptide-drug conjugates for antigen-specific Treg induction	55
Augmented the sensitivity of photothermal-ferroptosis therapy in triple-negative breast cancer through mitochondria-targeted nanoreactor	55
Splenic B cell-targeting lipid nanoparticles for safe and effective mRNA vaccine delivery	55
Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation	55
Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer	55
Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis	54
Shear force and cholesterol affinity responsive drug delivery system for treating inflammation and abnormal lipid metabolism in atherosclerosis	54
A bionic “Trojan horse”-like gene delivery system hybridized with tumor and macrophage cell membrane for cancer therapy	54
Nanoceria, the versatile nanoparticles: Promising biomedical applications	54
Stimuli-responsive and biomimetic delivery systems for sepsis and related complications	54
Bioengineered nanotechnology for nucleic acid delivery	54
Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy	54
A novel peptide hydrogel of metal ion clusters for accelerating bone defect regeneration	54
Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy	54
Smart delivery systems for microbial biofilm therapy: Dissecting design, drug release and toxicological features	53
Influence of focused ultrasound on locoregional drug delivery to the brain: Potential implications for brain tumor therapy	53
A glycopolymersome strategy for ‘drug-free’ treatment of diabetic nephropathy	53
Micelle-to-Gel: Thermosensitive intra-articular hydrogels for osteoarthritis management	53
Efficient pulmonary fibrosis therapy via regulating macrophage polarization using respirable cryptotanshinone-loaded liposomal microparticles	53
A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration	53
Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment	53
An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy	52
Determining topical product bioequivalence with stimulated Raman scattering microscopy	52
The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency	52
Locally delivered hydrogels with controlled release of nanoscale exosomes promote cardiac repair after myocardial infarction	52
Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response	52
Acid-base transformative HADLA micelles alleviate colitis by restoring adaptive immunity and gut microbiome	52
Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer	52
Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency	52
M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization	52
Cell microencapsulation technologies for sustained drug delivery: Latest advances in efficacy and biosafety	52
Intra-articular delivery of full-length antibodies through the use of an in situ forming depot	52
Levodopa-loaded nanoparticles for the treatment of Parkinson's disease	52
Gastrointestinal-inert prebiotic micro-composites improve the growth and community diversity of mucosal-associated bacteria.	52
Multifunctional nanocomposite hydrogel with dual-factor controlled release for stem cell recruitment, immunomodulation and bone remodeling	51
Construction of novel magnetic systems for cancer immunotherapy via cancer-immunity cycle circuits	51
Reinforcing vascular normalization therapy with a bi-directional nano-system to achieve therapeutic-friendly tumor microenvironment	51
Current state of the art in peptide-based gene delivery	51
A bifunctional nanocomplex with remineralizing and antibacterial activities to interrupt dental caries	51
Fine-tuning of liposome integrity for differentiated transcytosis and enhanced antitumor efficacy	51
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles	51
Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2	51
Recent advances in fluorescence imaging-guided photothermal therapy and photodynamic therapy for cancer: From near-infrared-I to near-infrared-II	51
Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates	50
Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration	50
Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression	50
Combating cisplatin-resistant lung cancer using a coiled-coil lipopeptides modified membrane fused drug delivery system	50
Protein-based nanocages for vaccine development	50
Red blood cell-mimicking liposomes loading curcumin promote diabetic wound healing	50
Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds	50
In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review	50